NewslettersMammary Cell NewsLong-Term Breast Cancer Response to CDK4/6 Inhibition Defined by TP53-Mediated GeroconversionBy Noshin Noorjahan - October 17, 2024032Using a large, clinically annotated cohort of patients with metastatic hormone receptor-positive breast cancer, scientists identified TP53 loss and MDM2 amplification to be associated with lack of long-term disease control.[Cancer Cell]Full ArticleGraphical Abstract